Company news

Insulet Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023

July 4, 2023

Insulet Celebrates One Year of Omnipod® 5 at the American Diabetes Association 83rd Scientific Sessions

June 21, 2023

Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom

June 19, 2023

Imperative Care Appoints Shacey Petrovic to Board of Directors

June 5, 2023

Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency¹)

May 3, 2023

Insulet Announces New Organizational Structure to Drive Further Growth

May 3, 2023

Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment

May 1, 2023

Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

April 24, 2023

Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023

March 29, 2023

CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency¹) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)

February 22, 2023

Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

February 20, 2023

Insulet Acquires Assets of Automated Glucose Control LLC (AGC)

February 13, 2023

Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies

February 12, 2023

Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

January 11, 2023

Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller

November 13, 2022

Insulet Issued Voluntary Medical Device Correction for Omnipod DASH® Personal Diabetes Manager on October 17, 2022

November 3, 2022

Insulet Reports Third Quarter 2022 Revenue Increase of 24% Year-Over-Year (29% Constant Currency¹)

November 2, 2022

Insulet Recognizes World Diabetes Day and Diabetes Awareness Month Throughout November

October 31, 2022

Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022

September 21, 2022

Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System

September 19, 2022

Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes

August 21, 2022

Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency¹)

August 3, 2022

Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System

July 31, 2022

Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022

June 29, 2022

Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes Over 12 Months of Use in Children Aged 2 through 5.9 Years

June 2, 2022

Insulet to Present at the William Blair & Company 42nd Annual Growth Stock Conference

June 1, 2022

Insulet Hosts Groundbreaking Ceremony for its New Manufacturing Facility in Malaysia

May 31, 2022

Insulet Reports First Quarter 2022 Revenue Increase of 17% Year-Over-Year

May 4, 2022

Insulet Announces CEO Transition

May 4, 2022

Insulet’s 2021 Sustainability Report Reveals Progress on Strategy to Deliver Growth with Purpose

May 1, 2022

Insulet Presents New Omnipod® 5 System Data for Type 1 and Type 2 Diabetes

April 26, 2022

Insulet to Announce First Quarter 2022 Financial Results on May 5, 2022

April 6, 2022

Insulet Reports Full Year 2021 Revenue Increase of 21% and Fourth Quarter 2021 Revenue Increase of 25% Year-Over-Year

February 22, 2022

Insulet Promotes Inclusivity for People with Diabetes through Nintendo® Video Game Animal Crossing™: New Horizons

February 16, 2022

Insulet Announces Board Appointment of Elizabeth Weatherman and Retirement of David Lemoine

February 6, 2022

Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control

January 27, 2022

CORRECTING and REPLACING Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

January 11, 2022

Insulet to Present at Nasdaq’s 45th Investor Conference

November 23, 2021

Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year

November 3, 2021

Insulet Honors Diabetes Awareness with Global Activities and Events

October 31, 2021

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

October 17, 2021

Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use

September 29, 2021

Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021

September 28, 2021

Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States

August 15, 2021

Insulet Introduces Omnipod DASH® System at Australasian Diabetes Congress

August 10, 2021

Insulet Reports Second Quarter 2021 Revenue Increase of 16% Year-Over-Year

August 4, 2021

Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021

June 30, 2021

Insulet’s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years

June 25, 2021

Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod® 5 System

June 23, 2021

Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year

May 5, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 28 decks. Every deck is listed under its year.